ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
24,80
-1,22
(-4,69%)
Fermé 17 Novembre 10:00PM
24,9494
0,1494
(0,60%)
Après les heures de négociation: 1:59AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
24,9494
Prix Achat
-
Prix Vente
-
Volume échangé
131 064 887
24,48 Fourchette du Jour 25,70
24,77 Plage de 52 semaines 31,54
Cap du marché
Clôture Veille
26,02
Ouverture
25,70
Dernière Transaction
6300
@
24.9494
(formt)
Dernière heure de transaction
Volume financier
US$ 3 260 066 190
VWAP
24,8737
Volume moyen (3 m)
34 104 330
Actions en circulation
5 666 990 035
Rendement du Dividende
6.73%
Ratio Cours sur Bénéfices
66,33
Bénéfice par action (BPA)
0,37
Chiffre d'affairess
58,5B
Bénéfice net
2,12B

À propos de Pfizer Inc

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
New York, New York, USA
Fondé
-
Pfizer Inc est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker PFE. Le dernier cours de clôture d'Pfizer était de US$26,02. Au cours de la dernière année, les actions de Pfizer ont été négociées dans une fourchette de prix de US$ 24,77 à US$ 31,54.

Pfizer compte actuellement 5 666 990 035 actions en circulation. La capitalisation boursière d'Pfizer est de US$147,46 milliard. Pfizer a un ratio cours/bénéfice (ratio PE) de 66.33.

Flux d'options Pfizer (PFE)

Flux global

Baissier

Prime nette

-94M

Calls / Puts

68,38%

Ach. / Vent.

104,08%

OTM / ITM

29,38%

Sweeps Ratio

0,44%

PFE Dernières nouvelles

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Andrew Baum, Chief Strategy and Innovation Officer, Executive Vice President...

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Aamir Malik, Chief U.S. Commercial Officer, Executive Vice President, at the...

Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

Third-Quarter Performance Driven by Focused Commercial Execution and Robust Double-Digit Revenue Growth Across Product Portfolio Raises Full-Year 2024 Revenue Guidance(1) to a Range of $61.0 to...

Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older

Millions of newly eligible U.S. adults aged 50 to 64 now recommended to receive vaccination against invasive pneumococcal disease (IPD) and pneumococcal pneumonia1 Pfizer Inc. (NYSE: PFE...

U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease

First and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 Approval based on data from pivotal Phase 3 trial in adults at increased risk of lower respiratory...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.1306-7.8677991137427.0827.1524.775123325226.3857975CS
4-4.3506-14.848464163829.329.36524.774397171527.72371622CS
12-3.8706-13.430256766128.8230.4324.773410433028.53412669CS
26-3.5406-12.427518427528.4931.5424.773386954128.75599827CS
52-4.2406-14.527577937629.1931.5424.773906029728.1252174CS
156-24.7306-49.779790660249.6861.7124.773045682738.08650361CS
260-11.6806-31.888069888136.6361.7124.773062364738.2162715CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BEBloom Energy Corporation
US$ 21,14
(59,19%)
65,71M
CMPCompass Minerals International Inc
US$ 14,50
(20,83%)
6,51M
GTN.AGray Television Inc
US$ 8,31
(20,78%)
151,3k
DESPDespegar com Corp
US$ 17,352
(16,77%)
5,18M
NRDYNerdy Inc
US$ 0,9631
(14,59%)
4,55M
GWHESS Tech Inc
US$ 5,20
(-29,06%)
327,95k
OKLOOklo Inc
US$ 17,995
(-24,64%)
36,34M
SAVESpirit Airlines Inc
US$ 1,0739
(-18,64%)
25,73M
ALURAllurion Technologies Inc
US$ 0,332
(-17,00%)
1,06M
EBSEmergent Biosolutions Inc
US$ 7,715
(-16,77%)
3,15M
PLTRPalantir Technologies Inc
US$ 65,77
(11,14%)
155,28M
PFEPfizer Inc
US$ 24,80
(-4,69%)
131,06M
BEBloom Energy Corporation
US$ 21,14
(59,19%)
65,71M
FFord Motor Company
US$ 11,01
(-0,54%)
58,9M
NUNu Holdings Ltd
US$ 14,055
(-7,47%)
49,95M
Aucune Discussion Trouvée
Ajouter une Discussion